Skip to main content Skip to navigation
Hamburger Menu
Search icon
Location Selector Location Selector
Czech Republic (English)
Profile Icon Profile Icon
Sign-in/Register UserName
Products

Link Arrow
Solutions

Link Arrow
Discover & Learn

Link Arrow
Resources & Tools

Link Arrow
Support

Link Arrow
Close Menu
Website Feedback
Alert Icon

Maximize Your Single Cell Insights

The power of multiomics makes your single cell research future proof turning a single experiment into insights about the many omes of each cell. With our complete solution you can now get more omes. More quality data. And more breakthroughs. All at less than 1 cent per cell.*

 

It's time to harness the power of more.
performance1

One Source, More Omes

Leave no cell behind and maximize insights about each single cell with coverage of DNA, RNA and Protein.

Less than 1 Cent per Cell

Gather more information, for less, with minimal cost per cell.

 

No Capital Instrument Expense

Get the high reproducibility and throughput of an instrument, without the usual price tag.

Simple and Free Data Analysis

Turn complex data into actionable insights with just a few clicks. Our high dimensional data analysis software requires no expertise and no coding.

The Only Complete Single-Cell Multiomics Solution

High data quality + high throughput + millions of cells, all in one solution.

 

Complete BD Solutions

 

 

 

The BD Difference

 

Features**10x GenomicsBDParse Biosciences or Scale Biosciences
High capital expenditure
Yes 
No
N/A
Sample loss
Clogging and wetting failures
None
Poor retrieval due to multiple pipetting steps
Hands-on time
Moderate
Moderate
High
Multiomics assays offered by same vendor
DNA (Epigenomics), RNA
DNA (Epigenomics), RNA, Protein
RNA
Inter-user variability
Low, except for clogging and wetting failures
Low to none
Potentially high, due to multiple pipetting steps
Fragile samples and granulocytes
Poor
Good capture and recovery
Poor
Long-term stopping point during the workflow
<4 weeks
1 year after cell capture on beads
<6months
Partial use consumables
No
Yes
No
Multiplet rate
High
Moderate
Low

 

Choose

Our validated assays and protocols support your single cell experiments, from 1 ome to many.
 
 
Choose
performance1

Generate

Fast track your single cell research without compromise

The BD Rhapsody™ HT Xpress System eliminates the need for expensive capital equipment or hours of pipetting into 96-well plates—providing reproducible, high-quality data, at less than 1 cent per cell.


With no capital expense, the cartridge-based system gives you the high-throughput you need to conduct million cell studies.

 
Analyze
performance1

Analyze

Go from sequencer to t-SNE plots with ease—for free
 
  • With no coding and no bioinformaticians needed, our free data analysis software finally makes uncovering insights simple and easy. You’ll also get access to our team of experts if you ever need additional support.

  • BD Rhapsody™ Sequence Analysis Pipeline: Simply load data from your sequencer and get ready-to-read, deconvoluted outputs.

  • BD CellismoTM Data Visualization Tool: Turn your data into insightful visualizations with our newest secondary analysis software.
 
Analyze
performance1

Latest News

Read our latest eBook to discover how single cell multiomics, the BD Rhapsody™ System, and cell sorting can help you gain important insights into cancer immunology.

Download e-Book
 
performance1
prev
next

The BD Rhapsody™ single-cell platform has been instrumental in advancing our translational research projects in inflammatory bowel disease (IBD) at Stanford. With the BD Rhapsody™ platform, we have been successful in robustly capturing traditionally difficult to isolate cell types (e.g. neutrophils) from intestinal biopsies. The platform has also enabled us to multiplex a large number of samples, capture significantly more cells, and perform advanced analyses combining whole transcriptomics with paired TCR and BCR sequencing.

The BD Rhapsody™ single-cell platform has been instrumental in advancing our translational research projects in inflammatory bowel disease (IBD) at Stanford. With the BD Rhapsody™ platform, we have been successful in robustly capturing traditionally difficult to isolate cell types (e.g. neutrophils) from intestinal biopsies. The platform has also enabled us to multiplex a large number of samples, capture significantly more cells, and perform advanced analyses combining whole transcriptomics with paired TCR and BCR sequencing.

John Gubatan, MD
Stanford University School of Medicine

The BD Rhapsody™ single-cell platform has been key for advancing our studies deciphering immunoregulatory networks in cancer and neglected diseases. We identified the cellular immune landscape using scarce human samples from tumors, lesions, and peripheral blood. We multiplexed four patient samples per cartridge using 10,000+ cells each to determine the activation state/functional potential of leukocytes in conjunction with their TCR or BCR variable region usage, thereby, allowing analysis of antigen specific responses with functional activity.

The BD Rhapsody™ single-cell platform has been key for advancing our studies deciphering immunoregulatory networks in cancer and neglected diseases. We identified the cellular immune landscape using scarce human samples from tumors, lesions, and peripheral blood. We multiplexed four patient samples per cartridge using 10,000+ cells each to determine the activation state/functional potential of leukocytes in conjunction with their TCR or BCR variable region usage, thereby, allowing analysis of antigen specific responses with functional activity.

Kenneth J. Gollob
Director
Center for Research Immuno-Oncology, São Paulo, Brazil

The BD Rhapsody™ single-cell platform has been a key tool for the publication of our clinical research. It allowed us to study gene expression from immune populations of frozen PBMCs from people living with HIV after a nutritional intervention. After the analysis, we got very interesting information about the changes in genes that were up or downregulated before and after the intervention. These subtle changes would not have been discovered without the use of a powerful, highly sensitive technique such as the BD Rhapsody™ single-cell platform.

The BD Rhapsody™ single-cell platform has been a key tool for the publication of our clinical research. It allowed us to study gene expression from immune populations of frozen PBMCs from people living with HIV after a nutritional intervention. After the analysis, we got very interesting information about the changes in genes that were up or downregulated before and after the intervention. These subtle changes would not have been discovered without the use of a powerful, highly sensitive technique such as the BD Rhapsody™ single-cell platform.

Olivia Yazmín Briceño Cárdenas, PhD
Researcher
Instituto Nacional de Enfermedades Respiratorias, Mexico City

We prefer the Rhapsody™ system for single cell RNA-Seq on our samples as it allows us to see what we have loaded before committing to expensive downstream analysis. The imaging is also indispensable for visualizing rare cancer cells in our liquid biopsy applications, as it provides insight even before characterizing the multiomic profile.

We prefer the Rhapsody™ system for single cell RNA-Seq on our samples as it allows us to see what we have loaded before committing to expensive downstream analysis. The imaging is also indispensable for visualizing rare cancer cells in our liquid biopsy applications, as it provides insight even before characterizing the multiomic profile.

Rob Salomon
Operations and Technical Manager, ACRF Child Cancer Liquid Biopsy Program
Children's Cancer Institute, Sydney

We as an early access user have adapted and rapidly expanded Rhapsody™ single cell multi-omics (WT, VDJ, AbSeq, and scATAC) services to a broad range of academic and industrial users. Our customers love BD Rhapsody™ 's super high capture capacity with multiplexing (SMK) approaches in the HT mode. It's robust, powerful, and cost-effective. The TCR/BCR Next works wonderfully as promised. The call rate of paired VDJ chains  is superior to almost all other single cell platforms.

We as an early access user have adapted and rapidly expanded Rhapsody™ single cell multi-omics (WT, VDJ, AbSeq, and scATAC) services to a broad range of academic and industrial users. Our customers love BD Rhapsody™ 's super high capture capacity with multiplexing (SMK) approaches in the HT mode. It's robust, powerful, and cost-effective. The TCR/BCR Next works wonderfully as promised. The call rate of paired VDJ chains  is superior to almost all other single cell platforms.

Xuhuai Ji
Lab Genomics Director
HIMC, Stanford University School of Medicine

The BD Rhapsody™ single-cell platform is an innovative device that lowers the threshold for single-cell transcriptomic research. It is highly effective in studying multiple samples simultaneously due to its multiplexing efficiency, utilizing various antibodies developed by BD over time. Additionally, since it does not use microfluidics for cell separation, it avoids clogging issues, making it suitable for studying cells from precious tissue samples.

The BD Rhapsody™ single-cell platform is an innovative device that lowers the threshold for single-cell transcriptomic research. It is highly effective in studying multiple samples simultaneously due to its multiplexing efficiency, utilizing various antibodies developed by BD over time. Additionally, since it does not use microfluidics for cell separation, it avoids clogging issues, making it suitable for studying cells from precious tissue samples.

TaeWoo Kwon
President/CEO
ROKIT Genomics, Seoul

The BD Rhapsody™ System has become one of our lab's most important single-cell analysis tools. Its precision, efficiency, and scalability have enabled us to uncover insights across a range of hematological cancers and healthy hematopoiesis at unprecedented resolution. It excels in its ability to generate high-quality single-cell proteo-genomics data of several hundreds of surface markers alongside transcriptomics data. Its intuitive design and high reproducibility has undoubtedly accelerated our research and opened up new avenues for discovery.

The BD Rhapsody™ System has become one of our lab's most important single-cell analysis tools. Its precision, efficiency, and scalability have enabled us to uncover insights across a range of hematological cancers and healthy hematopoiesis at unprecedented resolution. It excels in its ability to generate high-quality single-cell proteo-genomics data of several hundreds of surface markers alongside transcriptomics data. Its intuitive design and high reproducibility has undoubtedly accelerated our research and opened up new avenues for discovery.

Simon Haas, PhD
Berlin Institute of Health at Charité (BIH)
prev
next

Schedule a Meeting

Want to learn more about our solution? Contact us now to connect with our Multiomics Specialists.

 

 

*Required fields

*1 cent per cell calculation includes instruments and reagents, but is not inclusive of sequencing costs. 
** As of December, 2024
performance1

  

  

For Research Use Only. Not for use in diagnostic or therapeutic procedures.